- Home
- UNTY vs SEPN Comparison
UNTY vs SEPN Comparison
Compare UNTY & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNTY
- SEPN
- Stock Information
- Founded
- UNTY 1991
- SEPN 2022
- Country
- UNTY United States
- SEPN United States
- Employees
- UNTY N/A
- SEPN N/A
- Industry
- UNTY Major Banks
- SEPN
- Sector
- UNTY Finance
- SEPN
- Exchange
- UNTY Nasdaq
- SEPN NYSE
- Market Cap
- UNTY 458.0M
- SEPN 453.2M
- IPO Year
- UNTY 1997
- SEPN 2024
- Fundamental
- Price
- UNTY $51.50
- SEPN $11.76
- Analyst Decision
- UNTY Buy
- SEPN Strong Buy
- Analyst Count
- UNTY 2
- SEPN 5
- Target Price
- UNTY $52.50
- SEPN $26.75
- AVG Volume (30 Days)
- UNTY 95.8K
- SEPN 443.6K
- Earning Date
- UNTY 07-18-2025
- SEPN 08-15-2025
- Dividend Yield
- UNTY 1.08%
- SEPN N/A
- EPS Growth
- UNTY 11.85
- SEPN N/A
- EPS
- UNTY 4.26
- SEPN N/A
- Revenue
- UNTY $106,250,000.00
- SEPN $977,000.00
- Revenue This Year
- UNTY $21.68
- SEPN N/A
- Revenue Next Year
- UNTY $9.98
- SEPN $526.96
- P/E Ratio
- UNTY $12.12
- SEPN N/A
- Revenue Growth
- UNTY 6.60
- SEPN 108.76
- 52 Week Low
- UNTY $28.15
- SEPN $4.17
- 52 Week High
- UNTY $54.64
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- UNTY 79.98
- SEPN N/A
- Support Level
- UNTY $51.77
- SEPN N/A
- Resistance Level
- UNTY $53.39
- SEPN N/A
- Average True Range (ATR)
- UNTY 1.71
- SEPN 0.00
- MACD
- UNTY 0.72
- SEPN 0.00
- Stochastic Oscillator
- UNTY 96.80
- SEPN 0.00
About UNTY Unity Bancorp Inc.
Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.